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Annexin A6 (AnxA6) belongs to a family of Ca
21-depend-
ent membrane-binding proteins and is involved in the
regulation of endocytic and exocytic pathways. We
previously demonstrated that AnxA6 regulates receptor-
mediated endocytosis and lysosomal targeting of
low-density lipoproteins and translocates to choles-
terol-enriched late endosomes (LE). As cholesterol modu-
lates the membrane binding and the cellular location of
AnxA6, but also affects the intracellular distribution of
caveolin, we investigated the localization and trafficking
of caveolin in AnxA6-expressing cells. Here, we show that
cells expressing high levels of AnxA6 are characterized by
an accumulation of caveolin-1 (cav-1) in the Golgi com-
plex. This is associated with a sequestration of choles-
terol in the LE and lower levels of cholesterol in the Golgi
and the plasma membrane, both likely contributing to
retention of caveolin in the Golgi apparatusand areduced
number of caveolae at the cell surface. Further strength-
ening these findings, knock down of AnxA6 and the
ectopic expression of the Niemann–Pick C1 protein in
AnxA6-overexpressing cells restore the cellular distribu-
tion of cav-1 and cholesterol, respectively. In summary,
this study demonstrates that elevated expression levels
of AnxA6 perturb the intracellular distribution of choles-
terol, which indirectly inhibits the exit of caveolin from
the Golgi complex.
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Annexin A6 (AnxA6) is a member of a highly conserved
family of Ca
2þ- and membrane-binding proteins that have
been implicated in an array of physiological processes such
as cell proliferation, differentiation and signal transduction
(1,2). The different localization of each annexin in various
cells and tissues analyzed and the interaction of individual
annexins with different sets of membrane lipids and
proteins, together with their association with cytoskeletal
proteins, implicated a role for annexins in the regulation
of membrane fusion, targeting and vesicle formation in
endocytic and exocytic pathways (1,3). And indeed, in
recent years, the involvement of annexins in the regulation
of membrane traffic and membrane microdomain forma-
tion has emerged as one of their predominant functions. In
many cells and tissues analyzed, AnxA6 was found both at
the plasma membrane (PM) and in the early endosomes
(EE) (4–6). These localization studies correlate with the
stimulatory effect of ectopically expressed AnxA6 in
receptor-mediated endocytosis (7–9) and favor a role of
AnxA6 in the endocytic pathway.
Most cells and tissues express abundant amounts of AnxA6,
and in rat liver, baby hamster kidney (BHK), normal rat kidney
(NRK) cells and polarized WIF-B hepatocytes, immunocyto-
chemical studies identified AnxA6asaprominent component
not only of EE but also of late endosomes (LE)/prelysosomes,
Golgi compartments (6,10–12) and phagosomes (13). How-
ever, like all other annexins, AnxA6 is not expressed in some
cell types and tissues analyzed (2,4). For example, epithelial
cells of the small intestine and parathyroid gland and A431,
a vulval squamous epithelial carcinoma cell line, completely
lack AnxA6. Others, like colon epithelium, Chinese hamster
ovary (CHO) cells and several human breast cancer cells have
almost undetectable amounts of AnxA6 (2,8,14–16). These
findings suggest cell-specific functions of AnxA6 that are
associated with tightly controlled expression levels.
The regulation of the subcellular distribution of AnxA6 is
poorly understood, but in close relation with its multiple
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yet unidentified signals seem to promote targeting of
AnxA6 to certain cellular sites. Elevation of intracellular
Ca
2þ levels promotes the translocation of cytosolic AnxA6
to the PM and EE, where it is believed to bind to negatively
charged phospholipids (1,17). However, in the late endo-
somal/prelysosomal compartment, recent findings from
our laboratory suggest that cholesterol stimulates the
membrane-binding affinity of AnxA6 (14). We iden-
tified that accumulation of low-density lipoproteins (LDL)-
containing vesicles was accompanied by an increased
amount of AnxA6 in LE (8). In addition, we showed that
the expression of a dominant-negative mutant of AnxA6
inhibited the transport of LDL from the late endosomal/
prelysosomal compartment to lysosomes (7). Finally,
treatment with U18666A, a pharmacological agent that
leads to an accumulation of cholesterol in LE, resulted in
a significant and very specific translocation of both endogen-
ous and ectopically expressed AnxA6 but not AnxA2 or
caveolin in these vesicles in vivo (14). Although these
mechanisms do not seem to operate in all cells and the
healthy appearance of AnxA6 knockout (ko)-mice chal-
lenge the role of AnxA6 in this context (18,19), these
studies indicate a role for AnxA6 in the lysosomal targeting
and export of cholesterol from LE/prelysosomes.
Interestingly, studies on other proteins involved in the
transport of cholesterol from LE/prelysosomes to other
cellular compartments, such as Niemann–Pick C1 (NPC1),
revealed that this process might be linked to the localiza-
tion, trafficking and expression levels of caveolin-1 (cav-1)
and caveolin-2 (cav-2) at the trans Golgi network (TGN) and
at the PM (20–22). As AnxA6 in LE could be involved in the
delivery of cholesterol to caveolin-containing compart-
ments, we investigated its role in the subcellular localiza-
tion and membrane trafficking of caveolin. In the present
study, we demonstrate that increased expression of
AnxA6 results in a sequestration and reduced export of
cholesterol from LE, possibly by interacting and interfering
with NPC1 function. This imbalance of intracellular choles-
terol correlates with the accumulation of cav-1 in the Golgi
complex and a reduced number of caveolae at the cell
surface. The potential participation of AnxA6 in cholesterol
transport from the late endocytic compartment, the mech-
anisms and its consequences for caveolin export from the
Golgi complex are discussed.
Results
The AnxA6 is involved in cholesterol sequestration
and export from LE
To investigate the consequences of AnxA6 expression on
the intracellular distribution of cholesterol, wefirst compared
CHO wildtype (CHOwt) cells and a well-characterized CHO
cell line overexpressing AnxA6 [(CHOanx6); see Materials
and Methods for further details]. The CHOwt cells express
very low amounts of AnxA6 (7,8,15,23) (see also Figures 5C
and 8C and Figure S3C), whereas AnxA6 levels in CHOanx6
are rather similar to the AnxA6 expression observed in other
commonly used cell lines such as HeLa (Figure 5C).
The CHOwt and CHOanx6 cells were fixed, stained with
filipin, and the pattern of cholesterol staining was compared
by epifluorescence microscopy (Figure 1A). As expected, in
CHOwt cells, cholesterol was clearly detectable at the PM,
and in punctate, in part perinuclear, structures throughout
the cytoplasm. In contrast, 90% of CHOanx6 cells showed
a very different staining pattern; in particular, weak choles-
terol staining at the PM and a much stronger accumulation
of cholesterol in cytoplasmic, perinuclear vesicles (Figure 1
A). Both the size and fluorescence intensity of filipin-stained
vesicle cells were significantly increased in CHOanx6 com-
pared with CHOwt cells (Figure 1A; p < 0.001). Quantifica-
tion of only prominently enlarged cholesterol-containing
structures (defined as cytoplasmic, filipin-positive vesicles
with a Ø   0.5 mm and a relative intensity  0.4; seeinserts
and quantification in Figure 1A) confirmed an accumulation
of cholesterol in 45.7   14.6% of CHOanx6 cells with an
average of 3.2   0.7 filipin-positive perinuclear structures/
cell. In contrast, only 14.3   4.1% of control cells showed
similar structures with an average of 1.3   0.2 filipin-
positive structures/cell (p < 0.001).
To validate the strikingly different distribution of choles-
terol in the CHOanx6 cell line and to exclude an aberrant
phenotype as a consequence of cell line selection, we then
analyzed CHOwt cells transiently transfected with green
fluorescent protein (GFP)-tagged AnxA6 (GFP–Anx6). In
these set of experiments, and similar to the elevated levels
of AnxA6 in the CHOanx6 cell line (11.1   2.7-fold),
expression levels of GFP–Anx6 were increased 9.4  
3.5-fold compared with endogenous AnxA6 in CHOwt
cells (compare Figure S3B–C and Figures 5C and 8C).
Clearly, transient overexpression of AnxA6 resulted in an
accumulation of cholesterol in vesicular structures (Fig-
ure 1B; p < 0.01). The same results were obtained when
the filipin staining in A431 (A431wt) cells, which com-
pletely lack endogenous AnxA6 (15,18), and A431 stably
expressing AnxA6 [(A431anx6); Figure 1B, see also Fig-
ure 8C for AnxA6 expression levels] was compared. Thus,
not the CHOanx6 cell line selection but elevation of AnxA6
levels per se correlates with an accumulation of choles-
terol in vesicular structures. This is not because of the
increased internalization rates as AnxA6 alone does not
alter LDL endocytosis but requires the coexpression of the
LDL receptor to increase LDL uptake and degradation
(7,8). Similarly, high transferrin receptor coexpression re-
vealed a stimulatory role of Rab5 in endocytosis (24,25). To
identifyifAnxA6-induced accumulationsofcholesterolwere
in the late endocytic compartment, CHOwt and CHOanx6
cells were transfected with the LE marker GFP-tagged
Rab7 (Rab7–GFP) and stained with filipin. This showed
a substantial colocalization of Rab7–GFP and cholesterol in
CHOanx6 cells (Figure 1C, panels a–f). In support of this,
we also observed a significant colocalization of filipin with
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only in CHOanx6 cells (Figure 1C, panels g–l) but not in
controls. As shown previously in CHOanx6 and NRK cells
(7, 14), significant amounts of AnxA6 colocalized with
Rab7 in the late endosomal compartments of COS-1 cells
transiently cotransfected with Anx6– cyan fluorescent
protein (CFP) and Rab7–GFP (Figure 1D, panels a–c).
To confirm that expression of AnxA6 increases the content
of cholesterol in LE by biochemical means, cell lysates
Figure 1: Sequestration of cholesterol in the late endosomal compartment of AnxA6-expressing cells. A) The CHOwt and
CHOanx6 cells grown on coverslips were fixed and stained with filipin (5 mg/mL) as indicated. Arrows and arrowheads point at the
accumulation of cholesterol in perinuclear compartments and at the PM, respectively. B) The CHOwt cells transiently transfected with
GFP–Anx6 (a and b), AnxA6-deficient A431 cells (A431wt) and A431 cells stably expressing AnxA6 (A431anx6) were fixed and stained with
filipin (c and d). The arrows point at the accumulation of cholesterol in perinuclear vesicles of GFP–Anx6 expressing CHO and A431anx6
cells, compared with the non-transfected control (arrowheads). For the quantification in A (a and b) and B (a and b), see text for further
details. The mean values   SD of the diameter and fluorescence intensity of perinuclear filipin-positive structures from three independent
experiments (150 cells in total) per cell line is given; ** and ***, p < 0.01 and p < 0.001 for Student’s t-test, respectively. Inserts (in A)
show representative filipin-positive structures. C) The CHOwt and CHOanx6 cells were transfected   Rab7–GFP (a–c and d–f), fixed and
immunolabeled with anti-LBPA (g–i and j–l) and stained with filipin (a, d, g and j) as indicated. The merged images (c, f, i and l) show
a colocalization of cholesterol and LE in CHOanx6 cells (arrows in f and l). D) The COS-1 cells were cotransfected with Anx6–CFP (a) and
Rab7–GFP (b), fixed and analyzed by confocal microscopy. Arrows in the merged image (panel c) point at colocalization of Anx6–CFP and
Rab7–GFP. Bar is 50 mm in B (a and b) and 10 mm in all other panels. Figure 1 continued on next page.
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fractionation, and EE and LE were isolated on sucrose
gradients (8) and analyzed for their cholesterol (Figure 2A)
and phospholipid contents. The purity of isolated fractions
was routinely assessed by immunoblotting with estab-
lished markers for EE (Rab5 and EEA1), LE (Rab7 and
Lamp1), PM [Na
þK
þ adenosine triphosphatase (ATPase)]
and b-hexosaminidase activity assays (lysosomes) as
described (8,14) (Figure S1A). Similar to previous studies
(14), high-performance liquid chromatography analysis and
fluorometric determinations showed comparable levels of
cholesterol (Figure 2A) and phospholipids (phosphatidyl-
glycerol, phosphatidylethanolamine, phosphatidylinositol,
phosphatidylserine (PS) and phosphatidylcholine; unpub-
lished data) in EE fractions of both cell lines. In contrast,
and in agreement with the increased filipin staining (Fig-
ure 1A–C), LE from CHOanx6 cells contained more cho-
lesterol (55   12%; p < 0.01), whereas the molar ratio of
phospholipids remained unchanged. The differences in
late endosomal cholesterol levels measured biochemically
in CHOanx6 cells versus CHOwt cells (Figure 2A) appear
to be smaller than the differences in filipin staining
(Figure 1A–C) between these cells. However, these re-
sults are consistent with the reports showing that moder-
ate increases (30–40%) in late endosomal cholesterol result
in a dramatic intensification of filipin staining (26–29).
Late endosomal/prelysosomal cholesterol is exported to
various locations in the cell including the cell surface. In
normal cells at steady state, very little cholesterol is
detected in LE and lysosomes as cholesterol derived from
the hydrolysis of internalized LDL is rapidly transported out
Figure 1: Continued from previous page.
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labels the PM and to a lesser extent other intracellular
compartments such as recycling endosomes and the
Golgi. However, in the presence of U18666A, [
3H]-Chol
almost exclusively loads LE, and followed by incubation
with cholesterol acceptors like methyl-b-cyclodextrin (CD),
[
3H]-Chol from LE is available for efflux to the PM and can
be quantified (33,34). Although the CD-induced export of
cholesterol is significantly delayed under these conditions
and approximately fivefold to sevenfold less efficient as in
control CHO cells (33) (see also Figure S2A), it allows to
determine if cholesterol export from LE is affected upon
AnxA6 overexpression. The CHOwt and CHOanx6 cells
were incubated with U18666A in the presence of [
3H]-
Chol, followed by 1% CD for 120 min, and then the
radioactivity released into the media was measured (Fig-
ure 2B). Compared with controls, CHOanx6 cells showed
a 53.9   11.5% reduction (p < 0.05) in cholesterol efflux
upon incubation with CD. Similar results were obtained
when comparing other cell lines (A431 and BT20)  
AnxA6 (Figure S2B). Consistent with these findings, and
despite the total amount of free cholesterol being compa-
rable in both cell lines (Figure 2C), the cholesterol in
isolated PM fractions was significantly reduced by
42   12% (p < 0.05) in CHOanx6 cells (Figure 2C). Cho-
lesterol efflux induced with 1% CD or physiological cho-
lesterol acceptors [high-density lipoproteins (HDL), HDL3]
in the absence of U18666A, which will then predominantly
remove [
3H]-Chol derived from the PM, was reduced by
10–20% in CHOanx6 cells (Figure S2A). Although we
cannot completely rule out some contribution of efflux
from intracellular compartments in these experiments, it
is supportive of cholesterol at the PM being reduced in
CHOanx6 cells.
To address if cholesterol synthesis in AnxA6-expressing
cells could contribute to the reduced cholesterol levels at
the PM, CHOwt and CHOanx6 cells were labeled with
[1-
14C]-acetic acid. Newly synthesized radioactive choles-
terol was separated from its major precursors and ana-
lyzed by thin layer chromatography (TLC). The TLC plates
were exposed to X-ray film, quantified using ImageJ
[National Institutes of Health (NIH)] and normalized for
total cellular protein as described (35). Interestingly, in two
separate experiments with triplicate samples, relative
cholesterol synthesis was slightly reduced by 36   18%
(p < 0.05) in CHOanx6 cells (Figure S1B). Similar findings
Figure 2: Cholesterol imbalance in CHOanx6 cells. A) The EE
and LE from 4 to 6   10
7 CHOwt and CHOanx6 cells were
isolated as described (8,14) (see also Figure S1A), and cholesterol
(mg/mg cell protein) in each endosomal fraction was determined in
duplicate samples (see Materials and Methods). The mean   SD
is given and is representative for five independent experiments. *,
p < 0.05 for Student’s t-test. B) The CHOwt and CHOanx6 cells
were incubated with 2 mg/mL U18666A together with [
3H]-Chol
(2   10
6 c.p.m/mL) for 24 h. Cells were washed with PBS and
incubated   1% CD for 120 min. The ratio of released and cell-
associated radioactivity was determined, normalized to total cell
protein, and the amount of efflux is given in per cent. The
background efflux in U18666A-treated CHOwt and CHOanx6 cells
was equivalent to 5.0–7.0   10
5 c.p.m/mg cell protein, respect-
ively. Mean values   SD of three independent experiments with
triplicate samples are given. *, p < 0.05 for Student’s t-test. C)
Total cellular cholesterol and PM cholesterol (mg/mg cell protein)
were determined from whole cell lysates and PM fractions (15)
(see also Figure S1B) of CHOwt and CHOanx6 cells (in triplicate)
and normalized to cellular protein. The mean   SD is given and is
representative for three and five independent experiments,
respectively. *, p < 0.05 for Student’s t-test. D) The CHOwt cells
were incubated   U18666A (2 mg/mL) for 24 h as indicated, and
cholesterol levels in 500 mL of Golgi-enriched membrane fractions
were determined and compared with CHOanx6 cells. Mean
values   SD of two independent experiments with duplicate
samples are given.
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could be (i) because of a reduced expression/activity of
cholesterol synthetic enzymes in CHOanx6 cells or (ii)
linked to inhibitory effects of AnxA6 and cavDGV on the
Ras/PI3K/Akt signaling pathway in cholesterol synthesis
(15,23,35,36). However, although newly synthesized cho-
lesterol from the endoplasmic reticulam (ER) rapidly reaches
the cell surface (37), it is unlikely that this pathway plays
a major role in the reduction of cholesterol levels at the PM
(and the Golgi; Figure 2D) of CHOanx6 cells as the majority of
cellular cholesterol is derived from receptor-mediated uptake
of lipoproteins, which is accompanied by a downregulation of
cholesterol synthesis (31,32,37). In further support of this
observation, the total amount of cellular cholesterol remains
unchanged in CHOanx6 cells (Figure 2C).
Finally, to analyze if AnxA6-dependent reduction of cho-
lesterol export from LE could be linked to cholesterol-
dependent secretory pathways from the Golgi to the PM,
we compared cholesterol levels in Golgi-enriched mem-
brane fractions of CHOwt cells   U18666A with untreated
CHOanx6 cells. The purity of isolated Golgi-enriched
membrane fractions was confirmed through the enrich-
ment of cis- and trans-Golgi markers [(GM130, Golgi
microtubule-associated protein of 210kDa (GMAP210)
and TGN38) and the lack of significant amounts of EE, LE
(Rab5 and Rab7), PM (Na
þK
þ ATPase) or endoplasmic
reticulum (KDEL) markers (Figure S1C). As shown in
Figure 2D, isolated CHOwt cells Golgi membranes contain
6.0   0.4 mg cholesterol/mg cell protein, which is compa-
rable to previously reported values (38,39). In contrast,
CHOanx6 cells showed reduced (38.0   5.7%) choles-
terol levels in their Golgi fractions. Importantly, upon
treatment of CHOwt cells with U18666A, reduced choles-
terol levels in Golgi fractions were observed, which were
comparable to the values obtained from untreated
CHOanx6 cells. As newly synthesized cholesterol mostly
bypasses the Golgi complex on its way to the PM, and the
redistribution of internalized cholesterol from LE is the
major source of cholesterol in the Golgi (37), these findings
indicate that the blockage of cholesterol export from LE in
U18666A-treated CHO cells mimics the effects observed
in AnxA6-expressing cells, both ultimately leading to an
impaired supply of cholesterol to the Golgi.
In summary, we conclude that AnxA6 is involved in
cholesterol export from LE, and possibly in cholesterol
synthesis, thereby contributing to an imbalance and
altered distribution of cholesterol in other compartments
like the Golgi apparatus and the cell surface.
Expression of AnxA6 leads to the accumulation of
caveolin in the Golgi
We have recently shown that cholesterol regulates the
transport of caveolin through the Golgi complex (40). As
the export of cholesterol from LE could be linked to
caveolin trafficking and given the accumulation of late
endosomal cholesterol in CHOanx6 cells, we first com-
pared the localization of cav-1 in CHOwt cells and
CHOanx6 cells (Figure S3A). Both cell types express very
similar amounts of cav-1 and other proteins commonly
found in caveolae such as Scavenger receptor BI (SR-BI)
and H-Ras (15) (Figure S3C). Similar to other cell types,
cav-1 is localized at the PM and in the intracellular compart-
ments in CHOwt cells (images were taken with the focus
at the plane of the Golgi). However, in more than 90% of
AnxA6-expressing cells, a significant accumulation of
caveolin in the perinuclear region was observed. Quantifi-
cation of cav-1 fluorescence confirmed a 4.5   0.4-fold
(p < 0.001) increase of caveolin staining in the perinuclear
(Golgi) region of CHOanx6 cells compared with controls
(Figure S3A). To validate these findings, the localization of
cav-1 in CHOwt cells transiently transfected with GFP–
Anx6 was analyzed (Figure S3B). Similarly, cav-1 accumu-
lated 4.5   0.5-fold (p < 0.01) in the perinuclear region of
CHOwt cells upon GFP–Anx6 overexpression. Double
immunolabeling with polyclonal anti-caveolin and anti-
GM130, a marker protein for the cis-Golgi compartment,
revealed a remarkable colocalization in CHOanx6 cells
(Figure 3A, panel f). Quantification of cav-1 fluorescence
showed a 2.7   0.4-fold (p < 0.001) increase of caveolin
in the GM130-containing compartment of CHOanx6 cells
(Figure 3A).Comparable data were obtained using a mono-
clonal antibody specifically recognizing Golgi-associated
cav-1 (40) (Figure 3B, panels a and b).
Several caveolin antibodies preferentially recognize the
Golgi but not the PM pool of caveolin (40). To rule out that
expression of AnxA6 interfered with the antibody detec-
tion of caveolin at the PM, CHOwt and CHOanx6 cells
were transiently transfected with yellow fluorescent
protein (YFP)-tagged cav-1 (YFP–cav1) or GFP-tagged
caveolin-3 (GFP–cav3) and visualized by epifluore-
scence microscopy (Figure 3B, panels c–f). As shown for en-
dogenous cav-1, YFP–cav1 and GFP–cav3 were found in
intracellular compartments and in the PM in CHOwt cells.
In contrast, the majority of transfected CHOanx6 cells
(70–80%) were characterized by a strong accumulation of
both YFP–cav1 and GFP–cav3 in the perinuclear region,
further indicating a retention or slow export of caveolin
out of the Golgi complex.
By means of a biochemical approach developed recently in
our laboratory (40), the amount of cav-1 in the Golgi was
compared between both cell lines in immunoprecipitation
experiments (Figure 3C). These experiments confirmed
the increase of Golgi-associated cav-1 in CHOanx6 cells
(3.4   0.2-fold; p < 0.0001; see also Figure 4B and Figure
S4B). The Cav-1 immunoprecipitates did not contain
detectable amounts of AnxA6. Together with the lack of
colocalization of AnxA6 with cav-1 in Golgi compartments
(data not shown), this indicates that the increased associ-
ation of cav-1 with the Golgi in CHOanx6 cells is not
because of a direct interaction of AnxA6 with cav-1. In
support of the results described above, when Golgi
fractions from CHOwt and CHOanx6 cells were purified
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a 2.8   0.5-fold (p < 0.001) increase of cav-1 in Golgi
fractions from CHOanx6 cells (Figure 4D).
The CHOwt cells express small amounts of AnxA6 making
it difficult to detect in LE (14). To identify only residual
amounts of endogenous AnxA6 in LE of U18666A-treated
CHOwt cells, purified LE fractions had to be concentrated
10-fold (14). Similar to RNA interference (RNAi) knock-
down approaches (see also Figure 5C), we reasoned that
this very low concentration of AnxA6 in LE makes CHOwt
cells an appropriate model system to analyze if sequestra-
tion of cholesterol in LE per se can already lead to an
accumulation of cav-1 in the Golgi. Therefore, we first
Figure 3: Legend on next page.
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U18666A (Figure 4A). As expected, CHOwt cells incu-
bated with U18666A are characterized by increased
amounts of cholesterol in LE (Figure 4A, compare panels
g and h). In confirmation of previous results (14), treatment
with U18666A did not result in the recruitment of cav-1 to
LE, but a redistribution and increased cav-1 staining in the
Golgi in CHOwt cells were observed (compare panels
a and b). This correlates with a 4.1   2.3-fold enlargement
ofLE inCHOwt cells upon drugtreatment (compare panels
d and e), which can already be observed in untreated
CHOanx6 cells (panel f). It should be noted that CHOanx6
contained 2.5   0.3-fold more LBPA-positive vesicles
compared with CHOwt cells (compare panels d and f),
indicating a potential enlargement of the late endosomal
compartment. In support of these findings, immunopre-
cipitation of Golgi-associated cav-1 in CHOwt cells treated
with U18666A was increased 17.7   0.7-fold (p < 0.001)
compared with untreated CHOwt controls (Figure 4B). To
ensure that sequestration of cholesterol in LE in an AnxA6-
independent manner can result in an accumulation of cav-1
in the Golgi, we analyzed an AnxA6 ko-model using A431
(A431wt) cells (15,18). The A431wt were treated with
U18666A, and the Golgi-associated cav-1 was immuno-
precipitated and analyzed by Western blotting as described
above (Figure 4C). Like CHOwt cells (Figure 4B), A431
cells showed a 2.6   0.4-fold (p < 0.0001) increase of
cav-1 in the Golgi upon treatment with U18666A. These
findings suggest that the accumulation of late endosomal
cholesterol, possibly accompanied by LE vesicle enlarge-
ment as observed here and proposed by others (41), leads
to the concomitant retention of caveolin in the Golgi. In
summary, the results described above suggest that AnxA6
is a component of the molecular machinery involved in
cholesterol homeostasis that indirectly modulates the
export of cav-1 from the Golgi.
Downregulation of AnxA6 restores the intracellular
distribution of cholesterol and caveolin
We then transiently transfected CHOanx6 cells with
a myc-tagged N-terminal deletion AnxA6 mutant (previ-
ously described as dominant-negative DN-anx61–175) (Fig-
ure 5A), which interferes with the function of endogenous
AnxA6 in the endocytosis and delivery of LDL to lyso-
somes (7, 9). This mutant (Anx61–175) also seems to
interfere with the function of ectopically expressed AnxA6
as observed by the loss of the characteristic distribution,
size and number of enlarged, perinuclear filipin-positive
structures (Figure 5A, arrows in panel a; loss of vesicular
filipin-intensity in Anx61–175-transfected CHOanx6 cells:
2.5   0.5-fold; p < 0.0001). Furthermore, whereas cav-1
accumulates in the Golgi of CHOanx6 cells (Figure 5B,
arrows in panels a and c; see also Figures 3 and 4),
expression of the Anx61–175 mutant (Figure 5B, arrowhead
in panel a) strongly reduced the amounts of cav-1 at the
Golgi in 45–55% of transfected cells (loss of caveolin
staining in the Golgi in Anx61–175-transfected CHOanx6
cells: 4.3   0.3-fold; p < 0.0001). In contrast, CHOanx6
transfected with myc-tagged vector control (Figure 5B,
panels c and d) still show increased cav-1 staining at the
Golgi (arrowhead in panel c).
Then we analyzed the localization of cav-1 in AnxA6-
depleted HeLa cells, which normally express AnxA6 levels,
as shown for CHOanx6 cells that are significantly higher
(8.2   1.8-fold) compared with CHOwt cells (Figure 5C).
The RNAi-mediated downregulation of AnxA6 by 70–80%
did not affect cav-1 expression levels, but Golgi-cav-1
staining was strongly reduced (24.5   0.21-fold;
p < 0.001) in the majority (60–70%) of AnxA6-depleted
cells (arrowheads in Figure 5C) as compared with the
untransfected (arrows) or RNAi–GFP-transfected controls
(not shown). Next, we determined the amountsof immuno-
precipitated and Golgi-associated cav-1 after RNAi-
mediated depletion of AnxA6 (Figure 5D). In agreement
with the data obtained from the immunofluorescence
microscopy, Golgi-associated cav-1 in AnxA6-depleted
HeLa cells was reduced 2.6   0.3-fold (p < 0.001). We
then analyzed the distribution of cholesterol in AnxA6-
depleted HeLa cells (Figure 5C). In AnxA6-expressing con-
trols,astrongvesicularfilipinstainingwasobserved(arrows).
In contrast, AnxA6 depletion resulted in a redistribution
Figure 3: Caveolin accumulates in the cis-Golgi compartment of AnxA6-expressing cells. A) The CHOwt (a–c) and AnxA6-
expressingCHO cells (CHOanx6, d–f) grown on coverslips were fixed, permeabilized and stained with polyclonal anti-caveolin (green), anti-
GM130 (red) and 4,6-diamidino-2-phenylindole dihydrochloride (nuclei, blue) as indicated. The arrow points at caveolin (cav-1) accumulation
and colocalization with GM130 in the Golgi of CHOanx6 cells. Images, focused at the plane of the Golgi, are representative for 90% of cells
analyzed in each experiment (n ¼ 5). Bar is 10 mm. The fluorescence intensity of the cav-1 staining at the Golgi area in CHOwt and
CHOanx6 cells was quantified. Values represent the mean   SD of five independent experiments with 50 cells per cell line in each
experiment. ***, p < 0.001 for Student’s t-test. B) (a and b) The CHOwt and CHOanx6cells were fixed, permeabilized and immunolabeled
with mouse anti-cav-1 that specifically recognizes the Golgi-associated pool of cav-1. (c–f) The CHOwt and CHOanx6 cells were
transfected with YFP–cav1 and GFP–cav3 as indicated. Twenty-four hours after transfection, cells were fixed, and the localization of YFP–
cav1 and GFP–cav3 was analyzed by epifluorescence microscopy. Arrows point at the perinuclear accumulation of endogenous cav-1 (b)
and transfected YFP–cav1 (d) and GFP–cav3 (f) in CHOanx6 cells, respectively. Images are representative for 70–80% of cells analyzed in
five independent experiments. C) Golgi-associated caveolin was immunoprecipitated, analyzed by Western blotting as described (40) and
normalized to actin. The relative amount of cav-1 in the Golgi in both cell types is given and represents the mean   SD of five independent
experimentswithduplicatesamples.***,p < 0.001forStudent’st-test.D)Proteinlevelsofcaveolinin wholecelllysates(WCL)andGolgi-
enriched fractions (Golgi; see also Figure S1C) of CHOwt and CHOanx6 cells were determined by Western blot analysis and quantified.
Mean values   SD of three independent experiments with duplicate samples are given. **, p < 0.01 for Student’s t-test.
Traffic 2007; 8: 1568–1589 1575
Annexin A6 Regulates Caveolin TransportFigure 4: Legend on next page.
1576 Traffic 2007; 8: 1568–1589
Cubells et al.of cellular cholesterol with filipin predominantly staining
the PM and the perinuclear GM130-positive region (arrow-
heads). This correlates with increased cholesterol levels
(25   3.5%) in PM-enriched membrane fractions of
AnxA6-depleted cells (Figure 5E). Interestingly, depletion
of Rab9, which upon overexpression can compensate for
the accumulation of cholesterol in NPC-mutant cells (42–
44), does not change the filipin pattern of HeLa cells (45).
This indicates that more than a single pathway regulates
cholesterol export from LE and proteins like AnxA6 and
Rab9 drive efflux through different pathways. In summary,
loss or downregulation of AnxA6 correlates with a redis-
tribution of cholesterol, thereby modulating the intracel-
lular transport of cav-1 from the Golgi to other cellular
compartments.
U18666A-treated CHOwt cells and AnxA6-expressing cells
show a similar phenotype that partially resembles alter-
ations in cholesterol transport, observed in cells carrying
a mutation in the NPC1 protein. Given these similarities
and the predominant localization of NPC1 in LE, we
investigated if AnxA6 is linked to the function/localization
of NPC1. Immunofluorescence microscopy revealed the
colocalization of Anx6–CFP and GFP-tagged, wildtype
NPC1 (NPC1–GFP) in transiently transfected COS-1 cells
(Figure 6A). In addition, AnxA6 co-immunoprecipitated
with NPC1–GFP in lysates from transfected CHOanx6
cells (Figure 6B). Most importantly, ectopic expression of
NPC1–GFP in CHOanx6 cells resulted in a redistribution of
cav-1 (Figure 6C, panel a) and cholesterol (panel c), indi-
cating that overexpression of NPC1 overcomes the inhibi-
tory effect of AnxA6 on cholesterol export in LE, thereby
also releasing the blockage of cav-1 export from the Golgi
(Figure 6C).
The AnxA6 modulates the export of caveolin from
the Golgi complex
Given the requirement of cholesterol for caveolin export
from the Golgi (40) and the reduced Golgi–cholesterol in
CHOanx6 cells (Figure 2D), we determined the export of
caveolin from the Golgi complex of CHOwt and CHOanx6
cells in inverse fluorescence recovery after photobleach-
ing (iFRAP) experiments (40). In order to measure and
visualize the kinetics of caveolin export, and to avoid any
interference of GFP-tagged cav-1 with endogenous cav-1,
we monitored the localization of GFP-tagged caveolin-3
(cav-3) (GFP–cav3). We and others have shown that the
localization and trafficking of these two isoforms are
comparable in commonly used cell lines that do not
express cav-3 (36,40). Therefore, CHOwt and CHOanx6
cells were transfected with GFP–cav3, and the entire
cytoplasm except the Golgi region of transfected cells
was photobleached. Then GFP–cav3 trafficking from the
Golgi was monitored by confocal microscopy. Results
from individual cells were compared, and a representative
experiment is shown (Figure 7A, for quantification, see
Figure 7B). As hypothesized, 90 min after photobleach-
ing, 48   2.11% of GFP–cav3 fluorescence disappeared
from the Golgi in CHOwt cells (mobile fraction, for
quantification details, see Materials and Methods),
but much slower kinetics for GFP–cav3 export (mobile
fraction, 16   2.51%) from the Golgi were observed
in AnxA6-expressing cells (p < 0.01). Moreover, this
appeared to be specific for caveolin as the kinetics of
GFP–MAL, a raft-associated integral membrane protein at
the PM, and GFP-tagged epidermal growth factor recep-
tor (EGFR–GFP), which is found at the PM in both lipid
rafts and clathrin-coated pits, were almost identical in
CHOanx6 and controls (Figure 7B). Similar to published
data(40,46), the kineticsand cholesterol requirements for
the export of vesicular stomatitis virus-G protein [(VSV-
G)–GFP], a marker protein for the exocytic pathway, are in
striking contrast to cav-1 (see also Figure S5). Elevation of
cholesterol leads to a retention of VSV-G in the Golgi,
which was observed in both CHOwt and CHOanx6
cells. Consistent with our hypothesis of an impaired
supply of cholesterol to the Golgi in CHOanx6, one
could expect an increased mobility of Golgi-associated
VSV-G. Indeed, in the set of experiments performed
(Figure 7B), we observed a 20   2% increased mobility
of Golgi-associated VSV-G in CHOanx6 cells compared
with controls.
Wehaverecentlydemonstratedthatexogenouscholesterol
stimulates the exit of cav-1 from the Golgi (40). To deter-
mine if the accumulation and slow transit of caveolin
through the Golgi in CHOanx6 cells could be overcome by
cholesterol loading, iFRAP experiments   exogenous cho-
lesterol in CHOanx6 cells transiently transfected with GFP–
cav3, which behaveslike cav-1 inCHOanx6 (Figures 3B and
7A,B), were performed, and the kinetics of GFP–cav3
export were determined (Figure 7C). Clearly, addition of
exogenous cholesterol completely re-established the
onward trafficking of GFP–cav3 out of the Golgi complex
in CHOanx6 cells in vivo. Then, the localization of endoge-
nous cav-1 in controls and CHOanx6 cells   cholesterol
was compared (Figure S4A). Similarly, significantly less
cav-1 was associated with the Golgi complex upon addition
Figure 4: Sequestration of cholesterol in LE alters the cellular distribution of caveolin. A) The CHOwt and CHOanx6 cells were
treated   U18666A (2 mg/mL) for 24 h, fixed and stained with anti-caveolin, anti-LBPA and filipin (5 mg/mL) as indicated. A redistribution
and increased cav-1 staining in the Golgi of U18666A-treated CHOwt can be observed (panels b and n). The merged images are shown
(panels j–l). Bar is 10 mm. B and C) The CHOwt, CHOanx6 (B) and A431 (C) cells were treated   U18666A as above, and Golgi-associated
caveolin was immunoprecipitated and analyzed by Western blotting as described (40). Actin in the cell lysates is shown. The amount of
immunoprecipitated cav-1 from the Golgi was quantified and normalized to actin. The relative amount of cav-1 in the Golgi is given and is
representative for three independent experiments. ***, p < 0.001 for Student’s t-test.
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tectable in CHOanx6 cells (arrow in Figure S4A, panel d).
To corroborate these findings, Golgi-associated cav-1 was
quantified in immunoprecipitation experiments (Figure
S4B). The CHOwt and CHOanx6 cells were again incu-
bated   cholesterol for 90 min. Then the Golgi-associated
cav-1 was immunoprecipitated and quantified as described
(40) (see also Figures 3C, 4B,C and 5D). Control samples
confirmed increased amounts of cav-1 associated with the
Golgi complex in CHOanx6 cells (Figure S4B, compare
lanes 1 and 5 and 2 and 6, respectively; p < 0.001).
Addition of exogenous cholesterol reduced the amount
of cav-1 in the Golgi by 37 and 84% in CHOwt cells as well
as 63 and 68% in CHOanx6 cells   cycloheximide (Cyhx),
respectively (Figure S4B; p < 0.001).
Finally, toverify andidentify a possible correlation between
the level of AnxA6 expression, the accumulation of cav-1 in
the Golgi and the number of caveolae at the cell surface,
several cell types expressing high and low levels of AnxA6
were analyzed and compared by electron microscopy
(Figure 8A). The CHOanx6 cells had morphologically nor-
mal but reduced numbers (61.4%) of caveolae compared
with control cells (Figure 8B). Less caveolae (60.8%) were
also found in A431 stably expressing AnxA6 (A431anx6)
compared with AnxA6-deficient A431wt. Likewise, the
comparison of estrogen-receptor (ER) negative breast
cancer cell lines with high (MDA-MB-436) and low (MDA-
MB-468) AnxA6 levels showed a 55.0% reduction in the
number of caveolae in the ER-negative cells with high
AnxA6 expression levels. In addition, exogenous choles-
terol increased caveolae formation in CHOanx6 cells and
resulted in comparable numbers of caveolae in both cell
types (3.19   0.68 and 3.32   0.59 caveolae/section,
respectively). These findings correlated with a slight
decrease of HDL3-induced cholesterol efflux, which is
believed to be mediated through SR-BI in caveolae [(47)
and references therein], in CHOanx6 cells (10–20%)
compared with controls. Similar results were obtained
when cholesterol efflux was determined using 1% CD
(Figure S2A). Thus, we conclude that the overall ability of
CHOanx6 and other cell types with high AnxA6 expression
levels to form caveolae is not affected. In spite of this,
AnxA6-induced perturbations in cholesterol metabolism,
including late endosomal cholesterol export indirectly
reducing the exit of cav-1 from Golgi compartments, could
contribute to a reduced number of caveolae at the cell
surface. These results are also consistent with the
reduced number of caveolae observed in BHK cells treated
with U18666A (A. Pol and R. G. Parton, personal
communication).
Discussion
In this study, we have shown that high expression levels
of AnxA6 can induce a cholesterol imbalance, thereby
indirectly perturbating cav-1 export from the Golgi.
To our knowledge, only studies with (i) a dominant-
negative mutant of cav3, cavDGV, and (ii) mutants of the
NPC1 protein have shown a phenotype similar to AnxA6-
expressing cells and revealed a link between intracellular
cholesterol pools and caveolin localization.
Figure 5: Expression of an N-terminal deletion mutant or knock down of AnxA6 restores the cellular distribution of cholesterol
and cav-1. A) The CHOanx6 cells were transfected with Anx61–175 myc (a and b), fixed, stained with filipin (5 mg/mL) (a) and
immunolabeled with anti-myc (b) as indicated. Arrows point at vesicular, cholesterol-containing structures (a). Loss of strong perinuclear
filipin staining was observed in 50% of transfected cells in five independent experiments and quantified. The mean   SD of the relative
filipin intensity in the perinuclear region is given. B) The CHOanx6 cells were transfected with Anx61–175 myc (a and b) and empty vector
(c and d). Twenty-four hours after transfection, cells were fixed, permeabilized and immunolabeled with anti-cav-1 (a and c) and anti-myc
(b and d) as indicated. As shown in the schematic diagram, myc-tagged Anx61–175 contains the N-terminal signal peptide (blue) and two out
of eight AnxA6-membrane-binding repeats(gray). Arrowspoint at the increased amountof cav-1in theGolgi of non-transfected and vector-
transfected CHOanx6 cells (a and c). Arrowheads point at reduced and unchanged cav-1 staining at the Golgi in Anx61–175-transfected
(panel a) and control cells (panel c), respectively. Reduced cav-1 staining in the Golgi region upon Anx61–175 expression was observed in
45–55% of transfected cells in five independent experiments. The fluorescence intensity of the cav-1 staining at the Golgi in Anx61–175-
transfected versus non-transfected (panel a) and myc-transfected cells (panel c) were quantified. Values represent the mean   SD of 50
cells per cell line in each experiment (n ¼ 5). ***, p < 0.001 for Student’s t-test. Bar is 10 mm. C) HeLa cells were transfected with RNAi
targeting AnxA6 (RNAi–AnxA6) as described (15). Seventy-two hours after transfection, cells were fixed, permeabilized, immunolabeled
with anti-annexin A6 (AnxA6), anti-cav-1 (cav-1) and anti-GM130 and stained with filipin as indicated. Arrowheads point at cells with
downregulated AnxA6. Arrows show cells with unchanged AnxA6 expression levels and cav-1 staining (a and b) and vesicular filipin
staining (c and d). In three independent experiments, reduced amounts of cav-1 in the Golgi region (a and b) and increased filipin staining at
the PM (c and d) were observed in 60–70% of AnxA6-depleted cells. The fluorescence intensity of the cav-1 staining at the Golgi area in
non-depleted/depleted cells was quantified. Values represent the mean   SD of three independent experiments. ***, p < 0.001 for
Student’s t-test. Expression levels of AnxA6 in CHOanx6 (Anx6), CHOwt (wt) and HeLa   RNAi are given. Bar is 10 mm. D) HeLa cells
were transfected with RNAi–AnxA6 as above. Seventy-two hours after transfection, Golgi–caveolin was immunoprecipitated as described
in Figure. 4C. The relative amount of cav-1 in the Golgi was quantified and normalized to actin. Results represent the mean   SD of three
independent experiments with duplicate samples. **, p < 0.01 for Student’s t-test. E) The PM cholesterol (mg/mg cell protein) was
determined asdescribedabove(Figure2C) fromHeLacells transfected   RNAi–AnxA6 (in triplicate) andnormalizedto cellularprotein.The
mean   SD is given and is representative for two independent experiments.
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tants, including cavDGV, identified the C-terminal cyto-
plasmic domain being responsible for the targeting of
caveolin to the Golgi (48,49). Akin the accumulation of
endogenous cav-1 in the Golgi of AnxA6-expressing cells,
the cavDGV mutant is also retained in the cis-Golgi
complex. However, further striking similarities can be
observed. As shown for AnxA6 in this study, cavDGV
causes an intracellular accumulation of cholesterol in LE,
a decrease in cholesterol synthesis and cell surface
cholesterol, and a reduction in cholesterol efflux (21).
Moreover, cavDGV-transfected cells show a significantly
reduced number of caveolae. These changes in cavDGV-
expressing cells result in dramatic alterations in choles-
terol-dependent signaling events, such as the inhibition of
the H-Ras-induced activation of Raf-1, and subsequent
reduction of growth factor-dependent cell growth (36).
Along these lines, we recently showed that AnxA6 inhibits
the HDL-induced activation of H-Ras and Raf-1, which
requires the binding of HDL to SR-BI in caveolae (23,50).
In addition, AnxA6 reduces growth factor-induced Ras/
mitogen-activated protein kinase (MAPK) signaling and cell
proliferation in CHO and A431 cells (51,52) (T. Grewal, R.J.
Daly, C. Enrich, unpublished data). Thus, the mechanisms
underlying the effects of cavDGV and AnxA6 on choles-
terol and cav-1 transport could provide explanations for the
role of caveolae in the regulation of signal transduction and
cell growth.
The AnxA6 and cavDGV-expressing cells show a pheno-
type that partially resembles alterations in cholesterol
transport observed in cells carrying a mutation in the
NPC1 protein. The NPC1 is involved in cholesterol homeo-
stasis and has been proposed to regulate caveolin expres-
sion and localization (20,22). Although the function of
the NPC1 protein is not completely understood, NPC1-
deficient cells accumulate cholesterol in LE/prelysosomes,
delaying cholesterol transport to other caveolin-containing
cellular compartments (20,33,37,53) such as the TGN and
the PM. In NPC1 ko-cells, the total amount of caveolin at
the PM remains unaffected as these cells develop com-
pensatory mechanisms and increase the expression of
cav-1 and cav-2 (20). Another member of the NPC1 protein
family, NPC1L1, regulates cholesterol absorption at
the cell surface of enterocytes. This process appears
to involve cav-1 and AnxA2 (54–56), suggesting a co-
operativity of some annexins in NPC- and caveolin-depen-
dent cholesterol trafficking events (57). In conclusion,
Figure 6: The NPC1 restores the cellular distribution of cho-
lesterol and cav-1 in AnxA6-overexpressing cells. A) The COS-
1 cells were cotransfected with Anx6–CFP (b) and NPC1–GFP (c),
fixed, and analyzed by confocal microscopy. The merged image,
which is representative for 90% of cells analyzed, is shown in
panel a. Arrows in the enlarged sections (panels b and c) point at
colocalization of AnxA6ndash;CFP and NPC1–GFP. Bar is 10 mm.
B) The CHOanx6 cells were transfected with NPC1–GFP. Twenty
four hours after transfection, cell lysates (WCL) were immuno-
precipitated with or without ( ) a polyclonal antibody against GFP
(anti-GFP) as described (15) and analyzed by Western blotting for
the presence of NPC1–GFP and AnxA6. C) The CHOanx6 cells
were transfected with NPC1–GFP (b and d), fixed, permeabilized
and immunolabeled with anti-caveolin (a) and stained with filipin
(c). Cav-1 and cholesterol accumulation (arrows) in the Golgi and
LE (panels a and c) is lost upon overexpression of NPC1 (arrow-
heads in panels a and c). Bar is 10 mm.
1580 Traffic 2007; 8: 1568–1589
Cubells et al.Figure 7: Legend on next page.
Traffic 2007; 8: 1568–1589 1581
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indicate that the sequestration of cholesterol in the late
endocytic compartment and cholesterol synthesis are
potentially responsible for subsequent alterations in cav-1
localization/trafficking, cholesterol efflux and signaling
events at the PM.
However, whereas caveolin and NPC1/2 are cholesterol-
binding proteins and/or directly involved in cholesterol
transport, it is believed that annexins, like AnxA6, do not
directly interact with cholesterol. Up to date, only AnxA2
has yet been identified in a complex together with cav-1
and cholesterol (56,58). The AnxA6 is thought to pre-
dominantly bind to PS (1,58), whereas cholesterol asso-
ciates preferentially with phosphatidylcholine. Despite
these findings, we showed that accumulation of choles-
terol stimulates the binding of AnxA6 to LE (14). Similarly,
AnxA6 has been shown to relocalize to endocytic com-
partments in NPC1-deficient cells (59). Furthermore,
AnxA6 colocalizes with cav-1 at the PM and in the
endocytic compartments has been identified in Triton X-
100 (TX-100) insoluble, caveolin- and cholesterol-enriched
membrane fractions and translocates to cholesterol-rich
membranes in different cell types, including CHO cells
(1,17,60) (T. Grewal, K. Gaus, C. Enrich, unpublished data).
This indicates that cholesterol modulates the membrane
binding and subcellular distribution of AnxA6 (14), which in
turn regulates cholesterol and cav-1 transport. Although at
present, we cannot completely rule out a subset of AnxA6
proteins being targeted to cholesterol-rich membrane
domains at the PM (1,17,60), thereby controlling PM
cholesterol, caveolin distribution and caveolae formation,
we currently favor several possibilities of AnxA6 acting in
LE: AnxA6 could be involved in the formation of PS-rich
domains in LE, thereby affecting the activity of proteins
residing in neighboring cholesterol-rich domains that con-
trol cholesterol transport. Alternatively, the colocalization
and co-immunoprecipitation of AnxA6 and NPC1 could
indicate that AnxA6 directly downregulates NPC1 activity.
This would ultimately control the amount of cav-1 and
caveolae at the PM. In support of both models, we
showed that the accumulation of Golgi-associated cav-1
in CHOanx6 can be overcome upon addition of exogenous
cholesterol or overexpression of NPC1. The fact that
AnxA6 is found in the Golgi in some cell types such as
hepatocytes and WIF-B cells (6,10) could indicate a direct
involvement in cholesterol and cav-1 transport from this
compartment. Nevertheless, currently available antibodies
did not reveal significant amounts of AnxA6 in the Golgi of
CHOanx6 cells.
Recently, overexpression of late endosomal Rab proteins,
in particular Rab9 and the recycling/exocytic Rab8, were
shown to rescue the cholesterol accumulation in NPC1
mutant cells (42–44). The mechanisms linking NPC1 and
Rab proteins are yet unclear, but Rab-dependent mem-
brane transport seems to promote cholesterol export path-
ways from LE. Interestingly, RNAi experiments revealed
that Rab9 is not essential for cholesterol export from LE
in normal cells (45). Yet, accumulation of late endosomal
cholesterol interferes with the activity cycle of Rab’s
(42,45) that requires their release from the membrane into
the cytoplasm, and inhibition of Rab’s blocks removal of
cholesterol from LE (61). Thus, sequestration of Rab
proteins in LE membranes may contribute to the cellular
pathology of NPC-related disease. Future studies will have
to clarify if high levels of AnxA6, similar to NPC1 muta-
tions, interfere with the trafficking of late endosomal Rab
proteins between their target membrane and the cytosol.
The AnxA6 and the secretory pathway
Data presented in this study suggest that sequestration of
cholesterol in LE, possibly together with reduced choles-
terol synthesis, in CHOanx6 cells reduces the activity of
cholesterol-dependent secretory pathways thereby con-
tributing to an accumulation of cav-1 in the Golgi. This is
supported by several studies demonstrating that choles-
terol is a limiting factor for the formation of vesicles in the
secretory pathway. Both constitutive and regulated forma-
tion of secretory vesicles requires cholesterol. Depletion of
cholesterol inhibits the formation of secretory vesicles
from the TGN (62). Vice versa, increased cellular choles-
terol levels induce pronounced vesiculation and dispersal
of Golgi-derived vesicles (63). In this fashion, Stu ¨ven et al.
(38) showed that the cholesterol levels at the Golgi
complex must be precisely balanced to allow protein
transport to occur.
One candidate protein potentially inhibited by AnxA6 and
involved in vesiculation and tubulation events regulating
Figure 7: Annexin A6 modulates the export of caveolin from the Golgi. A) The CHOwt and CHOanx6 cells were transfected with
GFP–cav3 and imaged beforeand after photobleaching of the entire cell except for the Golgi region. The loss of fluorescence signal (iFRAP)
from the Golgi was monitored by time-lapse microscopy. To avoid fluorescence recovery from the novo synthesis, cells were treated with
Cyhx. Representative Golgi images from CHOwt (a–c) and CHOanx6 (d–f) cells show GFP–cav3 localization before (a and d) and after
bleaching at t ¼ 0 min (b and e) and t ¼ 90 min (c and f), respectively. A representative image from four independent experiments is
shown. Bar is 10 mm.B) Quantification of Golgi iFRAP kineticsof GFP–cav3,EGFR–GFP, GFP–MALand VSV-G–GFPin transfectedCHOwt
and CHOanx6 cells. Images were taken every 30 seconds (see Materials and Methods,t¼ 0–2500 seconds). Kinetic parameters (mobile
fractionin %   SDandhalf timeofequilibration inseconds)foreachproteininbothcell linesfromfour independentexperimentsare given.
**, p < 0.01 for Student’s t-test. C) Quantification of Golgi iFRAP kinetics of CHOanx6 cells transfected with GFP–cav3 as described in
A and incubated   cholesterol for 20 min as indicated. Images were taken every 30 seconds. The amount of the mobile fraction   SD (%)
in the Golgi is shown.
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the cholesterol-dependent cytoplasmic phospholipase A2
(cPLA2). The cPLA2 translocates to the Golgi apparatus in
response to increased cellular cholesterol levels (63), and
cPLA2 activity is cholesterol sensitive (64). Consistent with
this hypothesis, we determined a reduced cPLA2 activity in
CHOanx6 cells that can be rescued by addition of exogen-
ous cholesterol (unpublished data).
Figure 8: High AnxA6 expression lev-
els correlate with a reduced number of
caveolae at the cell surface. A) Mono-
layers of cells with low (CHOwt, A431wt
and MDA-MB-468; panels a, c and e) and
high (CHOanx6, A431anx6 and MDA-MB-
436; panels b, d and f) AnxA6 expression
levels (see Western blot analysis in C), or
CHOwt and CHOanx6 cells preincubated
with cholesterol were fixed, collected,
embedded in Spurr, and ultrathin sections
were analyzed by electron microscopy.
Bar is 1 mm in panels a and b and
0.5 mm in c, d, e and f, respectively. B)
Grids were systematically screened, and
the number of caveolae (arrowheads in A)
in each cell line was determined in random
fields of sections from images acquired
at the same magnification (25 000 ). For
each cell line and condition, over 50 cells
were examined with an estimated total
lineal surface of 500 mm. The average
numberofcaveolae/sectionandthereduc-
tion in the number of caveolae (%) from
three independent experiments are given.
C) Expression levels of AnxA6, cav-1 and
actin in the various cell lines analyzed
above are given.
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AnxA1, AnxB1 and AnxA5, on cPLA2 activity has also been
demonstrated (65). This could lead to reduced vesiculation
from the Golgi that would downregulate the availability of
newly synthesized cholesterol acceptors, such as cav-1,
for vesicular or non-vesicular export of cholesterol from LE
(66). Besides, annexins have also been related to other
aspects of the secretory pathway (1). The AnxA2 is
involved in Ca
2þ-regulated exocytosis (4). The AnxA13b
associates with sphingolipid and cholesterol-rich domains
of the TGN that are required for the budding to the apical
PM (67). However, other factors like dynamin (63), the
actin cytoskeleton (68) and calmodulin (69) are also
involved in this process suggesting that multifactorial
protein–lipid interactions facilitate Golgi vesiculation. From
these observations, one could envisage that individual
annexins modulate various steps of the secretory pathway
through different and possibly cholesterol-dependent
mechanisms.
The role of AnxA6 in the secretory pathway has not been
extensively investigated, and several reports suggested,
in agreement with this study, an inhibitory role in the
secretory process. First, Zaks and Creutz showed that
AnxA6 inhibits vesicle aggregation and fusion, mediated by
AnxA2 and AnxA7 (70). Second, AnxA6 is found in non-
lactating breast epithelial cells but is undetectable in similar
sections taken from lactating breast (71). Finally, hepato-
cytes expressing high levels of AnxA6 only contain a small
number of caveolae (72, 73). Asproposed by van Duyl et al.
(74), the interaction of caveolin and cholesterol may be
fundamental to the generation of caveolae. Defects in the
export of caveolin from the Golgi because of the loss of
Golgi exit information, exposure of retention signals or
conformational changes can contribute to regulate the
number of caveolae. Here, we show that alterations in
cholesterol transport caused by the expression of AnxA6
result in a slow export of cav-1 from the Golgi. Hence, it
is tempting to speculate that this process could include
availability of cholesterol for NPC1, cav-1 oligomerization
and the delivery of cholesterol to the PM. It is plausible
that in certain epithelial cells, including hepatocytes that
express abundant amounts of NPC1 (75), and AnxA6
(5,6,10), their interaction contributes to regulate the amount
of caveolin/caveolae and cholesterol at the cell surface.
Materials and Methods
Reagents and antibodies
Nutrient Mixture Ham’s F-12, DMEM, RPMI-1640, filipin, Cyhx and water-
soluble cholesterol, saponin, U18666A and CD were from Sigma. Percoll
was from Invitrogen. Protein A/G–Sepharose, [
3H]-Chol and paraformalde-
hyde (PFA) was from Electron Microscopy Sciences, and Mowiol was from
Calbiochem. Lipoprotein-deficient fetal calf serum (FCS) was prepared by
preparative ultracentrifugation as described (76). High-density lipoproteins
(HDL3, density 1.125–1.21 g/mL) were isolated from the plasma of
normolipidemic volunteers by sequential density gradient ultracentrifuga-
tion as described (50). After preparation, HDL3 was stored in KBr at 48Ca n d
dialyzed extensively against PBS before use. The construction of YFP-
caveolin-1 (YFP–cav1), GFP–cav3 and EGFR (EGFR–GFP) expression
vectors have been described previously (40,77). The GFP-tagged VSV-G
(VSV-G–GFP), Rab7 (Rab7–GFP), MAL (GFP–MAL) and NPC1 (NPC1–GFP)
were kindly provided by Dr J. Lippincott-Schwartz (NIH, Bethesda, MD,
USA), Dr A. Sorkin (University of Colorado, Denver, CO, USA), Dr M.A.
Alonso (Centro de Biologia Molecular ’severo Ochoa’, Universidad
Auto ´noma de Madrid, Madrid, Spain) and Dr P.G. Pentchev (NIH, Bethesda,
MD, USA), respectively. For the construction of expression vectors encod-
ing CFP-tagged AnxA6 (Anx6–CFP) and myc-tagged AnxA6 deletion mutant
Anx61–175 (7) (Anx61–175–myc), rat full length and a 542 bp HindIII–Asp1
AnxA6 fragment containing coding sequences from pos. þ1 to pos. þ526
were cloned into pECFP-C1 (Clontech) and pcDNA3.1A-myc-his (Invitro-
gen), respectively. For the construction of GFP-tagged AnxA6 (GFP–Anx6),
a 733 bp EGFP fragment was isolated from pEGFP (BD Transduction
Laboratories) and cloned immediately upstream the N-terminus of rat
AnxA6 in pcDNAanx6 (8). The RNAi targeting human AnxA6 and GFP were
from Santa Cruz Biotechnology. Polyclonal anti-caveolin (C13630), mouse
anti-caveolin (PM-associated cav-1) (C43420), mouse anti-GM130, mouse
anti-TGN38, mouse anti-GMAP210 were from BD Transduction Labora-
tories. Polyclonal anti-SR-BI and anti-actin were from Novus and MP
Biomedicals, respectively. Monoclonal anti-LBPA was kindly provided by
Dr J. Gruenberg (University of Geneva, Geneva, Switzerland). Mouse anti-
cav-1 (Golgi-associated cav-1) (03-76000) and horseradish peroxidase
(HRP)-conjugated secondary antibodies were from Zymed Laboratories.
Mouse anti-myc (9E10), rabbit anti-Rab5, rabbit anti-Rab7 and mouse anti-
HRas were from Santa Cruz Biotechnology. Mouse anti-a-1 Na
þ/K
þ ATPase
was from Upstate, mouse anti-KDEL-receptor was from Stressgen Biore-
agents, and rabbit anti-GFP was from Abcam. Alexa Fluor-conjugated
secondary antibodies and 4,6-diamidino-2-phenylindole dihydrochloride
were from Molecular Probes Inc.
Cell culture
The CHO cells were grown in Ham’s F-12, A431, HeLa and COS-1 cells in
DMEM, MDA-MB-468 and MDA-MB-436 in RPMI-1640 together with 10%
FCS, L-glutamine (2 mM), penicillin (100 U/mL) and streptomycin (100 mg/
mL)at 378C, 5% CO2.To generate stable AnxA6-overexpressing CHO cells,
1   10
6 cells were transfected with 10 mg of pcDNAanx6 and the
FUGENE 6 Transfection Reagent (Roche Molecular Biochemicals).
G418 (1 mg/mL) was added 24 h after transfection. After 2 weeks, G418-
resistant colonies were isolated and examined for expression of AnxA6 by
Western blotting and immunofluorescence (7,8,14). As described pre-
viously (8), CHOanx6 cells showed no obvious morphological alterations
of the endocytic compartment (Rab5, EEA1, Rab11 or the recycling of
transferrin), lysosomes, Golgi (GM130) or the endoplasmic reticulum by
immunofluorescence and electron microscopy (data not shown).
To generate the AnxA6-expressing A431 cell line, A431 cells were trans-
fected with pcDNAanx6 and selected as described above (15). For the
transienttransfectionofexpressionvectorsencodingAnx6,Anx61–175,ca v- 1,
cav-3, Rab7 and NPC1, 1   10
5 CHOwt, CHOanx6 or COS-1 cells were
transfected with 1.5 mg Qiagen-purified DNA and 4 mL of Lipofectamine
2000 (Invitrogen) in OptiMEM (Gibco BRL) according to the instructions of
the manufacturer. For the intracellular accumulation of cholesterol, cells
were treated for 24 h with U18666A (2 mg/mL) as described (14).
Cholesterol measurements and Cyhx/cholesterol
treatments
The amount of cholesterol in whole cell lysates (total cholesterol) and PM,
EE and LE fractions were determined using the Amplex Red Cholesterol
Assay Kit (Molecular Probes) as described (16). To determine the amount of
cholesterol in PM fractions, 1   10
7 CHOwt and CHOanx6 cells were
washed twice in 0.25 M sucrose, 1 mM ethylenediaminetetraacetic acid
(EDTA), 20 mM Tris–HCL, pH 7.8 plus protease inhibitors, collected, lysed
and centrifuged. The postnuclear supernatant (PNS) was layered on top
of 10 mL of 30% Percoll and centrifuged at 84 000  g for 30 min in
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Cubells et al.a Beckman 70.1 TI rotor as described (15). Fractions (1 mL) were taken
from top to bottom, and the amount of cholesterol in 50 mL of each fraction
was determined and normalized to total protein (78). To identify the PM-
containing fractions in the middle of the gradient, aliquots of each fraction
were analyzed for the distribution of Ras by Western blotting (15) (see also
Figure S1B).
For the determination of cholesterol in LE and EE, 4–6   10
7 CHOwt and
CHOanx6 cells were homogenized by 10 passages through a 22-gauge
needle, and endosomes were separated on sucrose gradients as described
(8,14). In brief, the cell homogenate was centrifuged, and the PNS was
brought to a final 42% sucrose (w/v) concentration. Then 35% sucrose,
25% sucrose and homogenization buffer were poured stepwise on top of
the PNS. The gradient was centrifuged for 90 min at 155 000  g. After
centrifugation, 1 mL fractions were collected from top to bottom, and
fractions representing EE and LE were pooled. Before further analysis, the
purity of fractions was routinely confirmed by Western blot analysis with
PM, EE and LE markers and b-hexosaminidase assays (8) (see also Figure
S1A). For the fluorometric quantification of cholesterol, 25 mL of LE and EE
together with cholesterol standards (Precinorm, Precipath; Roche
Molecular Biochemicals) were incubated in 24-well plates according to
the instructions of the manufacturer, and fluorescence was detected using
Fluorocount (Packard Instrument Co.).
To determinecholesterol levels in theGolgi apparatus, a modifiedmethod of
Balch and coworkers (79) described in detail by Bru ¨gger et al. (80) was used
to isolate Golgi membrane fractions from CHO cells. All procedures were
carried out at 48C. In brief, 4–5   10
9 cells were harvested, washed twice
with PBS, twice with breaking buffer (BB) (0.25 M sucrose in 10 mM Tris–
HCl, pH 7.4) and resuspended in four volumes of BB. Cells were homog-
enized by passing 25 times through a ball-bearing homogenizer (Balch
homogenizer), which disrupts EE and LE, butnot Golgi vesicles,and brought
to a sucrose concentration of 37% (w/w) by addition of 62% (w/w) sucrose.
Fourteen milliliters of sample was overlaid with 15 mL 35% (w/w) sucrose
and 9 mL 29% (w/w) sucrose (in 10 mM Tris–HCl, pH 7.4) and centrifuged
for 2.5 h at 82 700  g. Typically, 2 mL of a Golgi-enriched membrane
fraction was recovered at the 35–29% interphase. The purity of the isolated
Golgi membranes was confirmed by Western blot analysis with Golgi
(TGN38, GM130and GMAP210), EE (Rab5), LE (Rab7), PM (Na
þK
þ ATPase)
and endoplasmic reticulum (KDEL) markers (Figure S1C). To determine
cholesterol levels, 500 mg of purified Golgi fraction were mixed with 0.3 mL
KOH (33%), 0.3 mL of ethanol (95%) and incubated at 608C for 15 min as
described (81). After addition of 10 mL of hexane and 3 mL of distilled
water, samples were mixed, and 4 mL of the organic hexane phase were,
together with cholesterol standard (0–60 mg in ethanol), evaporated under
nitrogen. Two milliliters of freshly prepared ophtaladehyde solution (0.5 mg/
mL in glacial acetic acid) and after 5 min, 1 mL of concentrated sulfuric acid,
were added. After 10 min, the absorbance was read at 550 nm.
For the determination of cholesterol synthesis, 4   10
5 CHOwt
and CHOanx6 cells (in triplicate) were grown in media containing 5%
lipoprotein-deficient FCS and incubated overnight with 1 mCi/mL [1-
14C]-
acetic acid as described in Du et al. (35). Cells were washed twice in buffer
C( 5m M Tris–HCL, pH 7.5; 150 mM NaCl) and 0.2% BSA, twice in buffer C
alone and lysed in 1 mL of 0.1 M NaOH. Then cells were saponified with
1 mL of 75% (w/v) KOH, 2 mL ethanol, 20 mM butylated-hydroxytoluene,
20 mM EDTA at 708C for 1 h. After cooling, nonsaponifiable lipids were
extracted into hexane (3   3 mL) and evaporated to dryness. Lipid extracts
were redissolved in 100 mL hexane and separated by TLC using 4% (w/v)
silver-coated Silica Gel 60 F254 plates (Merck) and a mobile phase of
heptane:ethyl acetate (2:1, v/v). This method separates cholesterol from its
major precursors including desmosterol. For visualization and quantifica-
tion, TLC plates were exposed to X-ray film, quantified using ImageJ (NIH)
and normalized for total cellular protein (78).
To inhibit protein synthesis in some experiments, 10 mg/mL Cyhx (in
100 mM Hepes, pH 7.5) was added to the media for 90 min. For cholesterol
addition, cells were incubated with 30 mg/mL cholesterol and premixed at
room temperature for 30 min in DMEM by gentle agitation. When Cyhx
and cholesterol were used in combination, both were dissolved in DMEM.
The Cyhx completely inhibited protein synthesis as judged by the lack of
any detectable fluorescence after expression of GFP in the presence of
Cyhx for 24 h (unpublished data).
The RNAi-mediated inhibition of AnxA6
HeLa cells (1–2   10
6) were transfected in 2 mL medium with 10 nM
AnxA6 small interfering RNA (siRNA) and 6 mL of Lipofectamine 2000
reagent (Invitrogen) according to the instructions of the manufacturer as
described (15). Experiments were conducted 72 h after transfection. The
GFP siRNA was used as a negative control.
Efflux experiments
To measure cholesterol efflux from LE, cells were treated for 24 h  
U18666A (2 mg/mL) in the presence of [
3H]-Chol (2   10
6 c.p.m/mL). To
remove non-internalized [
3H]-Chol, cells were washed extensively, fol-
lowed by incubation in serum-free media   1% CD for 120 min. Then,
the radioactivity in the media and cell lysate was collected, determined by
scintillation counting (82) and normalized to total cellular protein (78). The
ratio of released and cell-associated radioactivity was determined and is
given in per cent. The background efflux obtained from U18666A-treated
CHOwt and CHOanx6 cells was 0.8–1.2% (equivalent to 5.0–7.0   10
5
c.p.m/mg cell protein), respectively.
For the determination of HDL3-induced cholesterol efflux, cells were
labeled with radioactive LDL. To label LDL with [
3H]-Chol, 100 mLo f[
3H]-
Chol (3.7 Mbq) was dried under liquid nitrogen, resuspended in 100 mLo f
DMEM þ 2% BSA and incubated overnight with 3–5 mg LDL in PBS and
10 mM EDTA at 378C. Non-incorporated [
3H]-Chol was removed by PD10
gel chromatography (Amersham Biosciences). Then 2–5   10
5 cells (in
triplicate) were incubated overnight with [
3H]-Chol–LDL (1   10
6 c.p.m/
mL), and non-internalized radioactivity was removed by extensive washing
with PBS. To determine HDL3-induced cholesterol efflux, cells were
incubated in Ham’s F12/0.1% BSA   5, 50 or 100 mg/mL HDL3 for 8 h.
The media were harvested, cells were lysed in 0.1 N NaOH, and the total
cellular protein was determined (78). The radioactivity in the media and cell
lysate was determined by scintillation counting (82). The ratio of released
and cell-associated radioactivity was determined and is given in per cent
as above.
Immunofluorescence
Cells were grown on coverslips and fixed with 4% PFA, washed, permea-
bilized with 0.1% saponin and incubated with primary and secondary
antibodies or filipin (5 mg/mL) as described elsewhere (21). At last, samples
were mounted in Mowiol, and the cells were observed using an oil-
immersion Plan-Apo63x/1.4 objective in an Axio-plan or Axiovert 200M
Zeiss microscope (Zeiss). In the Axio-plan microscope, the images were
captured with an AxioCam HRc camera and were digitally treated with
AXIOVISION 3.1 software. In the 200M microscope, the images were
captured with a Photometrics Cool Snap HQ camera controlled by SLIDE-
BOOK 3.0.10.5 software (Intelligent Imaging Innovation). Image analysis was
performed with ADOBE-PHOTOSHOP 7.0 software. To quantify the fluores-
cence intensity of cav-1 or cholesterol (filipin) staining, experiments were
performed in parallel, and images were captured using identical contrast
and exposure times. Utilizing NIH image (ImageJ), the area to be quantified
(e.g. Golgi for cav-1) was selected, the pixel intensity was determined, and
the average staining intensity (50–150 cells per cell line in –three to five
experiments, respectively) was calculated. For the quantification and size
determination (nm Ø) of LBPA-positive vesicles, 100 cells per cell line per
treatment in three independent experiments were analyzed.
Different experimental set-ups were used for the imaging of CFP- and
GFP-cotransfected cells and for filipin in GFP-transfected cells (see below).
For the imaging of CFP–Anx6 and GFP–Rab7 in COS-1 cells, a Leica
TCS-SL spectral confocal microscope with 63  oil immersion objective
lens (NA 1.32) was used. To resolve these two fluorophores, the following
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excitation beam splitter double dichroic 458/514 nm, emission detection
range 465–485 nm; for GFP, 488 nm laser line; excitation beam splitter
triple dichroic 488/543/633 nm, emission detection range 500–550 nm).
Images of filipin and GFP-labeled cells were acquired using a Leica
DMI6000B epifluorescence microscope equipped with a Leica DFC 350
FX monochroma camera and 100  oil immersion objective lens (NA 1.4).
Filipin was imaged using a 360-nm filter cube (40-nm bandpass) excitation
filter (cross-excitation of GFP is null or unappreciated), 400-nm longpass
dichromatic filter and 425-nm (longpass) emission filter. The GFP was
imaged using a 480-nm filter cube (40-nm bandpass) excitation filter (filipin
cannot be excited by 460–500 nm), 505-nm longpass dichromatic filter and
527-nm (30-nm bandpass)emission filter. This, together with the sequential
acquisition of images, made it possible to discard fluorescence bleed
through or cross excitation (measured using single labeled samples).
Photobleaching experiments and time-lapse
confocal microscopy
The iFRAP experiments were carried out using a Leica TCS SL laser
scanning confocal spectral microscope (Leica Microsystems) with Argon
and HeNe lasers attached to a Leica DMIRE2 inverted microscope
equipped with an incubation system with temperature and CO2 control.
For visualization of GFP, images were acquired using 63  oil immersion
objective lens (NA 1.32; 488 nm laser line; excitation beam splitter RSP
500, emission range detection 500–600 nm). The confocal pinhole was set
at 2–3 Airy units to minimize changes in fluorescence because of GFP-
tagged proteins moving away from the plane of focus. The whole
cytoplasm, except the Golgi of a GFP-fusion protein-transfected cell, was
photobleached using 50–80 scans with the 488 nm laser line at full power.
Prebleach and postbleach images were monitored at 30-second intervals
for 90 min. The excitation intensity was attenuated down to approximately
5% of the half laser power to avoid significant photobleaching. The relative
loss of fluorescence intensity in the unbleached region of interest and
overall photobleaching in the whole cell during the time series were
quantified using IMAGE PROCESSING LEICA CONFOCAL Software. Background
fluorescence was measured in a random field outside of the cells.
Fluorescence correction, normalization and kinetic parameters (mobile
fraction and half time of equilibration) of GFP-tagged proteins were
calculated according to Rabut and Ellenberg (83).
Immunoprecipitation and Western blotting
For the immunoprecipitation of Golgi-associated cav-1, the method pre-
viously described in Pol et al. (40) was used and 1   10
7 CHOwt, CHOanx6,
A431wt and HeLa cells were extracted with 1 mL of ice-cold 10 mM Tris,
pH 7.5, 150 mM NaCl, 5 mM EDTA and protease and phosphatase inhibi-
tors, supplemented with 0.1% TX-100. After removal of cell debris, the
amount of extracted protein was quantified (78). Two micrograms of anti-
caveolin (Golgi-associated cav-1) was mixed with 120 mg of sample for 2 h
at 48C and antibody/caveolin complexes were collected with protein A/G–
Sepharose and separated on 12% SDS–PAGE (see below).
For the co-immunoprecipitation of AnxA6 and NPC1, CHOanx6 were
transfected with GFP–NPC1, and immunoprecipitation of AnxA6 was
performed as described (15). Cells were washed twice in 5 mL of
homogenization buffer (HB) (50 mM Tris, 150 mM NaCl and 5 mM EDTA,
pH 8.0) and scraped in 1 mL of lysis buffer (HB plus 5 mM NaF, 0.2 mM
Na2VO3, 0.1% (v/v) Triton-X-100 and protease inhibitors). The protein
content was determined, and then 500–800 mg of cell lysate was incubated
with 2 mg of anti-AnxA6 (rabbit) and control antibodies for 120 min at 48C.
Then 6 mL of Protein G Sepharose (Pharmacia) was added, and samples
were incubated for 45 min at 48C, centrifuged and washed three times in
buffer HB. The immunoprecipitates were pelleted, washed and separated
by 12% SDS–PAGE.
After transfer to Immobilon membranes, AnxA6, cav-1 and NPC1 were
detected using polyclonal antibodies, respectively, followed by HRP-
conjugated secondary antibodies and enhanced chemiluminescence de-
tection (Amersham).
Electron microscopy
Cell monolayers on 10-cm dishes were rinsed with PBS and fixed with 2%
PFA and 2.5% glutaraldehyde in 0.1 M phosphate buffer for 1 h at room
temperature. Cells were gently scraped, collected and pelleted by centri-
fugation (5 min at 500  g). After three rinses in 0.1 M phosphate buffer,
pellets were postfixed in 1% OsO4–0.8% FeCNK for 90 min. Finally,
samples were embedded in Spurr (Sigma), and ultrathin sections were
analyzed with a Jeol1010 electron microscope. Grids were systematically
screened, and the number of caveolae (non-coated 50–80 nm surface flask-
shaped membrane invaginations) were determined in random fields of
sections from images acquired at the same magnification (25 000 ). For
each cell line and condition, over 50 cells were examined with an estimated
total lineal surface of 500 mm. Similar results were obtained in three
independent experiments.
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Supplementary Materials
Figure S1: (A–C) Western blot analysisof sucrose gradients (A), Percoll
gradients (B) and Golgi membrane fractions (C) from CHOwt cells. A)
Early and late endosomal membrane fractions (20 mg protein/fraction) are
characterized by the presence of Rab5 and Rab7 and are well separated
from the bulk membrane (Na
þ/K
þ ATPase) at the bottom of the gradient
(8,16). B) The PM-enriched membrane fractions (20 mg protein/fraction) are
characterized by the enrichment of Ras (15). Incubation of cells overnight
with [
3H]-Chol predominantly labels the Ras-containing fractions 4 and 5. C)
Analysis of Golgi membrane fractions (Golgi; 100 mg protein) and whole cell
lysates (WCL, 100 mg protein) shows the enrichment of Golgi markers
GM130, TGN38 and GMAP210 (79,80). No significant amounts of EE, LE
and PM markers (Rab5, Rab7, KDEL and Na
þ/K
þ ATPase) were detected.
Gradients from CHOanx6 cells showed similarly well separated endosomal,
PM and Golgi membrane fractions (not shown).
Figure S2: Cholesterol efflux is decreased in AnxA6-expressing cells.
A) The CHOwt and CHOanx6 were incubated with [
3H]-Chol (2   10
6
c.p.m/mL) for 24 h.Cells were washed with PBS and incubated 1% CD for
120 min. The ratio of released and cell-associated radioactivity was
determined, normalized to total cell protein, and the amount of efflux is
given in per cent. The background efflux obtained from CHOwt and
CHOanx6 cells was equivalent to 2.0–8.0   10
5 c.p.m/mg cell protein,
respectively. Mean values   SD of three independent experiments with
triplicate samples are given. *, p < 0.05 for Student’s t-test. Alternatively,
CHOwt and CHOanx6 cells were labeled overnight with [
3H]-Chol-LDL
(1   10
6 c.p.m/mL), and efflux was induced with 5–100 mg/mL HDL3 for
8 h as indicated. The percentage of [
3H]-Chol efflux was calculated as
described above and represents the mean   SD of three independent
experiments with triplicate samples. B) The A431wt, A431anx6, BT20wt
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Cubells et al.(express low amounts of AnxA6, unpublished data) and BT20anx6 were
incubated with 2 mg/mL U18666A together with [
3H]-Chol (2   10
6 c.p.m/
mL) for 24 h. Cells were washed with PBS and incubated 1% CD for
120 min. The ratio of released and cell-associated radioactivity was
determined, normalized to total cell protein, and the amount of efflux is
given in per cent. The background efflux in U18666A-treated cells was
equivalent to 3.0–6.0   10
5 c.p.m/mg cell protein, respectively. Mean
values   SD of three independent experiments with triplicate samples
are given. **, p < 0.01 for Student’s t-test. C) CHOwt and CHOanx6 cells
(4   10
5) (in triplicate) were grown in media containing 5% lipoprotein-
deficient FCS and incubated overnight with 1 mCi/mL [1-
14C]-acetic acid.
Lipids were extracted, and newly synthesized cholesterol was separated
from its major precursors including desmosterol by TLC as described (35).
For visualization and quantification, TLC plates were exposed to X-ray film,
and the amount of radioactive cholesterol was quantified using ImageJ
(NIH). Relative intensities were normalized for total cellular protein (78). The
mean values for a representative experiment are given. In two independent
experiments with triplicate samples, an overall reduction of cholesterol
synthesis in CHOanx6 cells by 36   18% (p < 0.05) was observed.
Figure S3: Caveolin accumulates in a perinuclear compartment of
AnxA6-expressing cells. A) The CHOwt (a) and CHOanx6 (b) cells grown
on coverslips were fixed, permeabilized and stained with polyclonal anti-
caveolin. Arrowheads point at the perinuclear accumulation of caveolin in
CHOanx6 cells. Images are representative for 90% of cells analyzed. The
fluorescence intensity of the perinuclear cav-1 staining in CHOwt and
CHOanx6 cells was quantified. Values represent the mean   SD of five
independent experiments with 50 cellsper cell linein eachexperiment.***,
p < 0.001forStudent’st-test.B)TheCHOwtcells(aandb)weretransiently
transfected with GFP–Anx6 and stained with polyclonal anti-caveolin.
Arrowheads point at the accumulation of cav-1 in the perinuclear Golgi
region of the transfected cell. The protein levels of cav-1, GFP–Anx6 and
endogenous AnxA6 in transfected (þ) and non-transfected ( ) CHOwt cells
are given. C) Western blot analysis of cav-1, Scavenger receptor BI (SR-BI),
H-Ras and AnxA6 from total cell lysates of CHOwt and CHOanx6 cells.
Figure S4: Cholesterol restores the cellular distribution of cav-1 in
CHOanx6 cells. The CHOwt cells (a and c) and CHOanx6 cells (b and d)
were grown on coverslips, incubated   cholesterol for 90 min, fixed,
permeabilized and immunolabeled with anti-caveolin as indicated. Images
are representative for three independent experiments. Arrows point at the
localization of endogenous cav-1 at the PM in CHOwt and CHOanx6 cells
upon addition of cholesterol (c and d). Bar is 10 mm. E) The CHOwt (lanes
1–4) and CHOanx6 cells (lanes 5–8) were incubated with cholesterol and
Cyhx for 90 min as indicated. Then the Golgi-associated cav-1 was
immunoprecipitated and analyzed by Western blotting as described (40).
The amount of immunoprecipitated cav-1 from the Golgi was quantified
and ormalized to actin. The relative amount of cav-1 in the Golgi is given and
is representative for three independent experiments. ***, p < 0.001 for
Student’s t-test.
Figure S5: Cholesterol restores the ability of CHOanx6 cells to re-
establish cholesterol sorting events of VSV-G. The CHOwt cells (a and
c) and CHOanx6 cells (b and d) were grown on coverslips and transfected
with VSV-G–GFP. Twenty-four hours after transfection, cells were incu-
bated   cholesterol for 90 min, fixed, permeabilized and analyzed by
epifluorescence microscopy. The arrow points at the perinuclear localiza-
tion of GFP-tagged VSV-G in CHOanx6 cells upon addition of cholesterol (d).
Results are representative for three independent experiments. Bar is
10 mm.
Supplemental materials are available as part of the online article at http://
www.blackwell-synergy.com
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